pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-383 |
Genomic Coordinates | chr8: 14853438 - 14853510 |
Synonyms | MIRN383, hsa-mir-383, MIR383 |
Description | Homo sapiens miR-383 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-383-5p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 7| AGAUCAGAAGGUGAUUGUGGCU |28 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | Cloned | DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | VEGFA | ||||||||||||||||||||
Synonyms | MVCD1, VEGF, VPF | ||||||||||||||||||||
Description | vascular endothelial growth factor A | ||||||||||||||||||||
Transcript | NM_001025369 | ||||||||||||||||||||
Other Transcripts | NM_001025367 , NM_001025368 , NM_001025366 , NM_001025370 , NM_001033756 , NM_001171622 , NM_001171623 , NM_001171624 , NM_001171625 , NM_001171626 , NM_001171627 , NM_001171628 , NM_001171629 , NM_001171630 , NM_003376 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on VEGFA | |||||||||||||||||||||
3'UTR of VEGFA (miRNA target sites are highlighted) |
>VEGFA|NM_001025369|3'UTR 1 CAAGCCGAGGCGGTGAGCCGGGCAGGAGGAAGGAGCCTCCCTCAGGGTTTCGGGAACCAGATCTCTCACCAGGAAAGACT 81 GATACAGAACGATCGATACAGAAACCACGCTGCCGCCACCACACCATCACCATCGACAGAACAGTCCTTAATCCAGAAAC 161 CTGAAATGAAGGAAGAGGAGACTCTGCGCAGAGCACTTTGGGTCCGGAGGGCGAGACTCCGGCGGAAGCATTCCCGGGCG 241 GGTGACCCAGCACGGTCCCTCTTGGAATTGGATTCGCCATTTTATTTTTCTTGCTGCTAAATCACCGAGCCCGGAAGATT 321 AGAGAGTTTTATTTCTGGGATTCCTGTAGACACACCCACCCACATACATACATTTATATATATATATATTATATATATAT 401 AAAAATAAATATCTCTATTTTATATATATAAAATATATATATTCTTTTTTTAAATTAACAGTGCTAATGTTATTGGTGTC 481 TTCACTGGATGTATTTGACTGCTGTGGACTTGAGTTGGGAGGGGAATGTTCCCACTCAGATCCTGACAGGGAAGAGGAGG 561 AGATGAGAGACTCTGGCATGATCTTTTTTTTGTCCCACTTGGTGGGGCCAGGGTCCTCTCCCCTGCCCAGGAATGTGCAA 641 GGCCAGGGCATGGGGGCAAATATGACCCAGTTTTGGGAACACCGACAAACCCAGCCCTGGCGCTGAGCCTCTCTACCCCA 721 GGTCAGACGGACAGAAAGACAGATCACAGGTACAGGGATGAGGACACCGGCTCTGACCAGGAGTTTGGGGAGCTTCAGGA 801 CATTGCTGTGCTTTGGGGATTCCCTCCACATGCTGCACGCGCATCTCGCCCCCAGGGGCACTGCCTGGAAGATTCAGGAG 881 CCTGGGCGGCCTTCGCTTACTCTCACCTGCTTCTGAGTTGCCCAGGAGACCACTGGCAGATGTCCCGGCGAAGAGAAGAG 961 ACACATTGTTGGAAGAAGCAGCCCATGACAGCTCCCCTTCCTGGGACTCGCCCTCATCCTCTTCCTGCTCCCCTTCCTGG 1041 GGTGCAGCCTAAAAGGACCTATGTCCTCACACCATTGAAACCACTAGTTCTGTCCCCCCAGGAGACCTGGTTGTGTGTGT 1121 GTGAGTGGTTGACCTTCCTCCATCCCCTGGTCCTTCCCTTCCCTTCCCGAGGCACAGAGAGACAGGGCAGGATCCACGTG 1201 CCCATTGTGGAGGCAGAGAAAAGAGAAAGTGTTTTATATACGGTACTTATTTAATATCCCTTTTTAATTAGAAATTAAAA 1281 CAGTTAATTTAATTAAAGAGTAGGGTTTTTTTTCAGTATTCTTGGTTAATATTTAATTTCAACTATTTATGAGATGTATC 1361 TTTTGCTCTCTCTTGCTCTCTTATTTGTACCGGTTTTTGTATATAAAATTCATGTTTCCAATCTCTCTCTCCCTGATCGG 1441 TGACAGTCACTAGCTTATCTTGAACAGATATTTAATTTTGCTAACACTCAGCTCTGCCCTCCCCGATCCCCTGGCTCCCC 1521 AGCACACATTCCTTTGAAATAAGGTTTCAATATACATCTACATACTATATATATATTTGGCAACTTGTATTTGTGTGTAT 1601 ATATATATATATATGTTTATGTATATATGTGATTCTGATAAAATAGACATTGCTATTCTGTTTTTTATATGTAAAAACAA 1681 AACAAGAAAAAATAGAGAATTCTACATACTAAATCTCTCTCCTTTTTTAATTTTAATATTTGTTATCATTTATTTATTGG 1761 TGCTACTGTTTATCCGTAATAATTGTGGGGAAAAGATATTAACATCACGTCTTTGTCTCTAGTGCAGTTTTTCGAGATAT 1841 TCCGTAGTACATATTTATTTTTAAACAACGACAAAGAAATACAGATATATCTTAAAAAAAAAAAAGCATTTTGTATTAAA 1921 GAATTTAATTCTGATCTCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Cos-7 |
Location of target site | 3'UTR |
Tools used in this research | FindTar |
Original Description (Extracted from the article) |
...
{This MTI is shown in Fig. 1 and Fig. 2}
... - Ye W; Lv Q; Wong CK; Hu S; Fu C; Hua Z; Cai et al., 2008, PloS one. |
Article |
- Ye W; Lv Q; Wong CK; Hu S; Fu C; Hua Z; Cai et al. - PloS one, 2008
MicroRNAs (miRNAs) guide posttranscriptional repression of mRNAs. Hundreds of miRNAs have been identified but the target identification of mammalian mRNAs is still a difficult task due to a poor understanding of the interaction between miRNAs and the miRNA recognizing element (MRE). In recent research, the importance of the 5' end of the miRNA:MRE duplex has been emphasized and the effect of the tail region addressed, but the role of the central loop has largely remained unexplored. Here we examined the effect of the loop region in miRNA:MRE duplexes and found that the location of the central loop is one of the important factors affecting the efficiency of gene regulation mediated by miRNAs. It was further determined that the addition of a loop score combining both location and size as a new criterion for predicting MREs and their cognate miRNAs significantly decreased the false positive rates and increased the specificity of MRE prediction.
LinkOut: [PMID: 18320040]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
96 hsa-miR-383-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT004443 | VEGFA | vascular endothelial growth factor A | 5 | 2 | ||||||||
MIRT006137 | DIO1 | iodothyronine deiodinase 1 | 3 | 1 | ||||||||
MIRT006535 | IRF1 | interferon regulatory factor 1 | 3 | 1 | ||||||||
MIRT007246 | IGF1R | insulin like growth factor 1 receptor | 1 | 1 | ||||||||
MIRT007305 | PRDX3 | peroxiredoxin 3 | 1 | 1 | ||||||||
MIRT054359 | CCND1 | cyclin D1 | 4 | 2 | ||||||||
MIRT057087 | DDIT4 | DNA damage inducible transcript 4 | 2 | 2 | ||||||||
MIRT086536 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 2 | ||||||||
MIRT086544 | MOB4 | MOB family member 4, phocein | 2 | 2 | ||||||||
MIRT438194 | PPP1R10 | protein phosphatase 1 regulatory subunit 10 | 3 | 1 | ||||||||
MIRT448282 | ZMYM2 | zinc finger MYM-type containing 2 | 2 | 2 | ||||||||
MIRT451601 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | 2 | 2 | ||||||||
MIRT453387 | RHD | Rh blood group D antigen | 2 | 2 | ||||||||
MIRT458521 | C5orf22 | chromosome 5 open reading frame 22 | 2 | 2 | ||||||||
MIRT459720 | SGK494 | uncharacterized serine/threonine-protein kinase SgK494 | 2 | 2 | ||||||||
MIRT461491 | KIAA1009 | centrosomal protein 162 | 1 | 1 | ||||||||
MIRT463261 | ZIC5 | Zic family member 5 | 2 | 2 | ||||||||
MIRT464237 | VCP | valosin containing protein | 2 | 2 | ||||||||
MIRT465320 | TRAF5 | TNF receptor associated factor 5 | 2 | 2 | ||||||||
MIRT465774 | TMOD3 | tropomodulin 3 | 2 | 2 | ||||||||
MIRT467879 | SLC22A23 | solute carrier family 22 member 23 | 2 | 2 | ||||||||
MIRT469636 | RAD21 | RAD21 cohesin complex component | 2 | 6 | ||||||||
MIRT472041 | NPAT | nuclear protein, coactivator of histone transcription | 2 | 2 | ||||||||
MIRT476568 | GABARAPL1 | GABA type A receptor associated protein like 1 | 2 | 2 | ||||||||
MIRT478586 | CTDSPL2 | CTD small phosphatase like 2 | 2 | 2 | ||||||||
MIRT478870 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT482202 | AHR | aryl hydrocarbon receptor | 2 | 2 | ||||||||
MIRT484237 | IER2 | immediate early response 2 | 2 | 2 | ||||||||
MIRT487480 | NRF1 | nuclear respiratory factor 1 | 2 | 6 | ||||||||
MIRT493746 | GRAP2 | GRB2-related adaptor protein 2 | 2 | 2 | ||||||||
MIRT496836 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT497234 | APOL2 | apolipoprotein L2 | 2 | 2 | ||||||||
MIRT499424 | PLCG2 | phospholipase C gamma 2 | 2 | 9 | ||||||||
MIRT500598 | UBN2 | ubinuclein 2 | 2 | 10 | ||||||||
MIRT502859 | CHEK2 | checkpoint kinase 2 | 2 | 6 | ||||||||
MIRT507727 | CLIC4 | chloride intracellular channel 4 | 2 | 4 | ||||||||
MIRT510509 | YOD1 | YOD1 deubiquitinase | 2 | 6 | ||||||||
MIRT511901 | FNBP1L | formin binding protein 1 like | 2 | 6 | ||||||||
MIRT514393 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT520180 | WBP2 | WW domain binding protein 2 | 2 | 4 | ||||||||
MIRT531214 | PLA2G4D | phospholipase A2 group IVD | 2 | 2 | ||||||||
MIRT532846 | ZNF699 | zinc finger protein 699 | 2 | 2 | ||||||||
MIRT533461 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT539263 | ANKRD44 | ankyrin repeat domain 44 | 2 | 2 | ||||||||
MIRT539380 | ADSS | adenylosuccinate synthase | 2 | 6 | ||||||||
MIRT548129 | GAS1 | growth arrest specific 1 | 2 | 2 | ||||||||
MIRT550662 | ZFP37 | ZFP37 zinc finger protein | 2 | 2 | ||||||||
MIRT551499 | CENPN | centromere protein N | 2 | 2 | ||||||||
MIRT553778 | TAF13 | TATA-box binding protein associated factor 13 | 2 | 2 | ||||||||
MIRT554376 | SFPQ | splicing factor proline and glutamine rich | 2 | 2 | ||||||||
MIRT555821 | PCDH11Y | protocadherin 11 Y-linked | 2 | 4 | ||||||||
MIRT557558 | GOSR1 | golgi SNAP receptor complex member 1 | 2 | 2 | ||||||||
MIRT557694 | GATA6 | GATA binding protein 6 | 2 | 2 | ||||||||
MIRT561383 | TWF1 | twinfilin actin binding protein 1 | 2 | 2 | ||||||||
MIRT561414 | TSN | translin | 2 | 2 | ||||||||
MIRT561867 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT567383 | GTPBP3 | GTP binding protein 3, mitochondrial | 2 | 2 | ||||||||
MIRT569272 | PCDH11X | protocadherin 11 X-linked | 2 | 2 | ||||||||
MIRT569556 | UNC119B | unc-119 lipid binding chaperone B | 2 | 2 | ||||||||
MIRT569760 | RIMBP3C | RIMS binding protein 3C | 2 | 5 | ||||||||
MIRT573387 | GGA2 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | 2 | 2 | ||||||||
MIRT573456 | RPL41 | ribosomal protein L41 | 2 | 2 | ||||||||
MIRT573968 | DDX21 | DExD-box helicase 21 | 2 | 2 | ||||||||
MIRT574163 | ATG10 | autophagy related 10 | 2 | 2 | ||||||||
MIRT574659 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT574907 | Plcg2 | phospholipase C, gamma 2 | 2 | 6 | ||||||||
MIRT607496 | HEBP2 | heme binding protein 2 | 2 | 2 | ||||||||
MIRT612840 | KCNJ12 | potassium voltage-gated channel subfamily J member 12 | 2 | 4 | ||||||||
MIRT613962 | TMEM59 | transmembrane protein 59 | 2 | 2 | ||||||||
MIRT621125 | PCNXL2 | pecanex homolog 2 | 2 | 2 | ||||||||
MIRT625216 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT643337 | MICA | MHC class I polypeptide-related sequence A | 2 | 2 | ||||||||
MIRT646342 | CLIC6 | chloride intracellular channel 6 | 2 | 2 | ||||||||
MIRT647361 | WDR5B | WD repeat domain 5B | 2 | 2 | ||||||||
MIRT650308 | SLC35E2 | solute carrier family 35 member E2 | 2 | 2 | ||||||||
MIRT651372 | ZBTB21 | zinc finger and BTB domain containing 21 | 2 | 2 | ||||||||
MIRT655301 | PEAR1 | platelet endothelial aggregation receptor 1 | 2 | 2 | ||||||||
MIRT681918 | SLC11A2 | solute carrier family 11 member 2 | 2 | 2 | ||||||||
MIRT684165 | ALDH1B1 | aldehyde dehydrogenase 1 family member B1 | 2 | 2 | ||||||||
MIRT688053 | GLUL | glutamate-ammonia ligase | 2 | 2 | ||||||||
MIRT690210 | C5orf45 | MRN complex interacting protein | 2 | 2 | ||||||||
MIRT691024 | CRTC3 | CREB regulated transcription coactivator 3 | 2 | 2 | ||||||||
MIRT697699 | WAC | WW domain containing adaptor with coiled-coil | 2 | 2 | ||||||||
MIRT698201 | TMEM30A | transmembrane protein 30A | 2 | 2 | ||||||||
MIRT698857 | SRSF2 | serine and arginine rich splicing factor 2 | 2 | 2 | ||||||||
MIRT702292 | LDHA | lactate dehydrogenase A | 4 | 2 | ||||||||
MIRT703341 | GDPD5 | glycerophosphodiester phosphodiesterase domain containing 5 | 2 | 2 | ||||||||
MIRT704082 | DYRK2 | dual specificity tyrosine phosphorylation regulated kinase 2 | 2 | 2 | ||||||||
MIRT713729 | SUCO | SUN domain containing ossification factor | 2 | 2 | ||||||||
MIRT719487 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT722080 | SMC2 | structural maintenance of chromosomes 2 | 2 | 2 | ||||||||
MIRT724102 | TMEM199 | transmembrane protein 199 | 2 | 2 | ||||||||
MIRT725124 | SYNRG | synergin gamma | 2 | 2 | ||||||||
MIRT725601 | CAPN6 | calpain 6 | 2 | 2 | ||||||||
MIRT737186 | RBM3 | RNA binding motif (RNP1, RRM) protein 3 | 4 | 0 | ||||||||
MIRT755379 | NOS3 | nitric oxide synthase 3 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|